Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Graham

Showing results (1161-1170 of 1,460) with videos related to

Pageof 146
Sort By:
Plos One|October 27, 2017
Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virusMallika Sastry, Baoshan Zhang, Man Chen, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
Surveillance for Lyme disease in Canada: 2009-2015S Gasmi, N H Ogden, L R Lindsay, et al.
Science (New York, N.Y.)|February 27, 2016
Structural and molecular basis for Ebola virus neutralization by protective human antibodiesJohn Misasi, Morgan S A Gilman, Masaru Kanekiyo, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics ApproachJerry Li, Mina Nikanjam, Coleen K Cunningham, et al.
Plos Pathogens|July 11, 2015
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion GlycoproteinMorgan S A Gilman, Syed M Moin, Vicente Mas, et al.
Journal of Virology|May 5, 2017
Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion ProteinA Leemans, M De Schryver, W Van der Gucht, et al.
AIDS Research and Human Retroviruses|June 30, 2000
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation GroupM J McElrath, L Corey, D Montefiori, et al.
Immunity|September 30, 2019
Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza VirusMaya Sangesland, Larance Ronsard, Samuel W Kazer, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Antigen spacing on protein nanoparticles influences antibody responses to vaccinationDaniel Ellis, Annie Dosey, Seyhan Boyoglu-Barnum, et al.
Plos One|May 8, 2015
DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trialJulie E Ledgerwood, Abbie R Bellamy, Robert Belshe, et al.
Pageof 146

Showing results (1161-1170 of 1,460) with videos related to

Sort By:
Pageof 146
Plos One|October 27, 2017
Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virusMallika Sastry, Baoshan Zhang, Man Chen, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
Surveillance for Lyme disease in Canada: 2009-2015S Gasmi, N H Ogden, L R Lindsay, et al.
Science (New York, N.Y.)|February 27, 2016
Structural and molecular basis for Ebola virus neutralization by protective human antibodiesJohn Misasi, Morgan S A Gilman, Masaru Kanekiyo, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics ApproachJerry Li, Mina Nikanjam, Coleen K Cunningham, et al.
Plos Pathogens|July 11, 2015
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion GlycoproteinMorgan S A Gilman, Syed M Moin, Vicente Mas, et al.
Journal of Virology|May 5, 2017
Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion ProteinA Leemans, M De Schryver, W Van der Gucht, et al.
AIDS Research and Human Retroviruses|June 30, 2000
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation GroupM J McElrath, L Corey, D Montefiori, et al.
Immunity|September 30, 2019
Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza VirusMaya Sangesland, Larance Ronsard, Samuel W Kazer, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Antigen spacing on protein nanoparticles influences antibody responses to vaccinationDaniel Ellis, Annie Dosey, Seyhan Boyoglu-Barnum, et al.
Plos One|May 8, 2015
DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trialJulie E Ledgerwood, Abbie R Bellamy, Robert Belshe, et al.
Pageof 146